The top medtech stories of early 2017

The new Trump administration and Republican Congress – and all the accompanying change and uncertainty –is the major story for the medical device industry. But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, a

Pages: 1 2 3 4 5 6

House GOP healthcare plan would kill the medical device tax

Brad Perriello, Executive Editor A plan to repeal and replace the Affordable Care Act floated by Republicans yesterday – which critics have already dubbed “Trumpcare” or “Obamacare Lite” – would permanently repeal the medical device tax effective Jan. 1, 2018. A hold on the 2.3% tax on U.S. medical device sales went into effect at the beginning

Report: Precision Extrusion to add jobs after medical device tax suspension

Precision Extrusion is reportedly adding to its workforce now that the medical device tax has been temporarily suspended. President Barack Obama last month signed an omnibus tax and spending bill that pauses the medical device tax for 2 years. The 2-year hiatus on the 2.3% levy on all U.S. sales of medical devices is estimated to cost $3.4 billion,

Device tax relief: Four things the medtech industry needs to do now

In the aftermath of celebrating the two-year break from the device tax, we now have to turn to the practical side. We’ve won a battle and it is essential that industry not lose the war. But if the medtech industry can’t make the case that it will use device tax money to grow, it will

Lawmakers freeze medical device tax

In an early Christmas (or a late Hanukkah) for the medical device industry, lawmakers last week enacted a two-year freeze on the device tax. The $1.8 trillion federal spending and tax package that Congress passed Dec. 18 included a moratorium on the 2.3 percent tax on the revenues of medical device companies for certain products. The tax,